Recent Security Class Actions
MEI Pharma Inc. Common Stock (NASDAQ: MEIP)
Company Name:MEI Pharma Inc. Common Stock
Stock Symbol:NASDAQ: MEIP
Class Period Start:08/02/2017
Class Period End (inclusive):07/01/2020
Filing Deadline:10/09/2020
According to the Complaint, MEI Pharma was founded in 2000 and is based in San Diego, California. The Company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma is a late-stage pharmaceutical company that focuses on the development of various therapies for the treatment of cancer. MEI Pharma’s clinical drug candidates include, among others, Pracinostat, an oral histone deacetylase inhibitor.
